Literature DB >> 11905656

The role of complementary and alternative medicine in cancer.

E Ernst1.   

Abstract

Many cancer patients use complementary and alternative medicines. Oncologists therefore need to learn more about this subject. Dietary treatments, herbal medicinal products, and various food supplements are currently being promoted as 'cancer cures', but none of these treatments are backed up by convincing clinical evidence. For some interventions, however, the evidence is sufficiently encouraging to warrant further research. Several forms of complementary and alternative medicine play a part in supportive care for cancer patients. The evidence for this approach is still preliminary but, generally speaking, promising. The challenge for the future is to obtain reliable evidence and to identify those approaches that do more good than harm.

Entities:  

Mesh:

Year:  2000        PMID: 11905656     DOI: 10.1016/s1470-2045(00)00031-0

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


  18 in total

1.  Complementary or alternative medicine: the need for plausibility.

Authors:  L John Hoffer
Journal:  CMAJ       Date:  2003-01-21       Impact factor: 8.262

2.  Isolation and chemopreventive evaluation of novel naphthoquinone compounds from Alkanna tinctoria.

Authors:  Nguyen Huu Tung; Guang-Jian Du; Chun-Su Yuan; Yukihiro Shoyama; Chong-Zhi Wang
Journal:  Anticancer Drugs       Date:  2013-11       Impact factor: 2.248

3.  Prevalence of complementary and alternative medicine use in cancer patients during treatment.

Authors:  Jennifer S Yates; Karen M Mustian; Gary R Morrow; Leslie J Gillies; Devi Padmanaban; James N Atkins; Brian Issell; Jeffrey J Kirshner; Lauren K Colman
Journal:  Support Care Cancer       Date:  2005-02-15       Impact factor: 3.603

4.  Ginsenoside compound K, not Rb1, possesses potential chemopreventive activities in human colorectal cancer.

Authors:  Chong-Zhi Wang; Guang-Jian Du; Zhiyu Zhang; Xiao-Dong Wen; Tyler Calway; Zhong Zhen; Mark W Musch; Marc Bissonnette; Eugene B Chang; Chun-Su Yuan
Journal:  Int J Oncol       Date:  2012-03-12       Impact factor: 5.650

5.  Herbal medicines as adjuvants for cancer therapeutics.

Authors:  Chong-Zhi Wang; Tyler Calway; Chun-Su Yuan
Journal:  Am J Chin Med       Date:  2012       Impact factor: 4.667

6.  Falcarindiol and dichloromethane fraction are bioactive components in Oplopanax elatus: Colorectal cancer chemoprevention via induction of apoptosis and G2/M cell cycle arrest mediated by cyclin A upregulation.

Authors:  Chong-Zhi Wang; Yun Luo; Wei-Hua Huang; Jinxiang Zeng; Chun-Feng Zhang; Mallory Lager; Wei Du; Ming Xu; Chun-Su Yuan
Journal:  J Appl Biomed       Date:  2021       Impact factor: 1.797

7.  Laughter and humor as complementary and alternative medicines for dementia patients.

Authors:  Masatoshi Takeda; Ryota Hashimoto; Takashi Kudo; Masayasu Okochi; Shinji Tagami; Takashi Morihara; Golam Sadick; Toshihisa Tanaka
Journal:  BMC Complement Altern Med       Date:  2010-06-18       Impact factor: 3.659

8.  Complementary and alternative medicine (CAM) use among elderly Australian women who have cancer.

Authors:  David Sibbritt; Jon Adams; Gary Easthope; Anne Young
Journal:  Support Care Cancer       Date:  2003-07-10       Impact factor: 3.603

Review 9.  Complications of traditional Chinese/herbal medicines (TCM)--a guide for perplexed oncologists and other cancer caregivers.

Authors:  Joanne Chiu; Thomas Yau; Richard J Epstein
Journal:  Support Care Cancer       Date:  2008-11-14       Impact factor: 3.603

10.  Use of Traditional Chinese Herbal Medicine Concurrently with Conventional Cancer Treatment Among Chinese Cancer Patients.

Authors:  Jennifer Leng; Lei Lei; Shu Fang Lei; Zhiying Zhu; Alex Ocampo; Francesca Gany
Journal:  J Immigr Minor Health       Date:  2020-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.